Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Apax Global Alpha
Jam yesterday, and tomorrow, but not today
2nd Apr 2025
The Monthly: April 2025
1st Apr 2025
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
112: How to grow UK venture capital and exciting news | Richard Hoskins of Kin Group
Stay up-to-date with the latest research
Sign up to our newsletter
Life Sciences research
Allergy Therapeutics plc
Life Sciences
Disruptive peanut allergy vaccine
By
Dr Martin Hall
13 Feb 2017
Alliance Pharma Plc
Life Sciences
Potential of Diclectin
By
Dr Martin Hall
25 Jan 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Allergy Therapeutics plc
Life Sciences
Investment driving market share gains
By
Dr Martin Hall
20 Jan 2017
Diurnal Group Plc
Life Sciences
Infacort® – On track to market
By
Dr Martin Hall
19 Jan 2017
Prev
1
...
20
21
22
